Phibro Animal Health Corporation filed a Form 8-K with the U.S. Securities and Exchange Commission on August 26, 2026, disclosing operating results for its fourth quarter and fiscal year ended June 30, 2026, along with financial guidance for the fiscal year ending June 30, 2027.

Key Highlights

  • Reporting period covered: Fourth quarter and full fiscal year ended June 30, 2026.
  • Guidance included: Financial guidance for the fiscal year ending June 30, 2027 was announced alongside results.
  • Press release attached: The operating results and guidance were communicated via a press release dated August 26, 2026, furnished as Exhibit 99.1.
  • Furnished, not filed: The filing states the information "shall not be deemed to be 'filed' for purposes of Section 18" of the Securities Exchange Act of 1934.
  • Signatory: The report was signed by Judith Weinstein, Senior Vice President, General Counsel and Corporate Secretary.

Phibro Animal Health Discloses Fiscal 2026 Results and Fiscal 2027 Outlook via 8-K

Phibro Animal Health Corporation (NASDAQ:PAHC), a Delaware-incorporated company headquartered at Glenpointe Centre East, 300 Frank W. Burr Boulevard, Suite 21, Teaneck, New Jersey, filed a current report on August 26, 2026 under Item 2.02 (Results of Operations and Financial Condition). According to the filing, the company issued a press release on that date announcing operating results for the fourth quarter and the fiscal year ended June 30, 2026.

The filing also noted that the press release included financial guidance for the fiscal year ending June 30, 2027. The press release was furnished as Exhibit 99.1 to the current report. The filing disclosed that the information, including the attached exhibit, "is being furnished and shall not be deemed to be 'filed' for purposes of Section 18 of, or otherwise regarded as filed under, the Securities Exchange Act of 1934, as amended," and that it shall not be deemed incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act, except where expressly set forth by specific reference.

No detailed financial figures were contained within the body of the 8-K itself; the substantive financial data is held within Exhibit 99.1, the press release. The filing was signed on behalf of the registrant by Judith Weinstein in her capacity as Senior Vice President, General Counsel and Corporate Secretary.

What Was Disclosed

Phibro Animal Health filed an 8-K on August 26, 2026 to notify the public that it had released fourth-quarter and full fiscal year 2026 operating results, together with fiscal year 2027 financial guidance, via a press release furnished as an exhibit.